Search Results - "Shabsovich, David"

Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa by Joseph Davey, Dvora L, Nyemba, Dorothy C, Gomba, Yolanda, Bekker, Linda-Gail, Taleghani, Sophia, DiTullio, David J, Shabsovich, David, Gorbach, Pamina M, Coates, Thomas J, Klausner, Jeffrey D, Myer, Landon

“…Sexually transmitted infections (STIs) are associated with adverse outcomes in pregnancy, including mother-to-child HIV transmission. Yet there are limited…”
Get full text

Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients by Levin-Epstein, Rebecca, Cook, Ryan R., Wong, J. Karen, Stock, Richard G., Jeffrey Demanes, D., Collins, Sean P., Aghdam, Nima, Suy, Simeng, Mantz, Constantine, Katz, Alan J., Nickols, Nicholas G., Miszczyk, Leszek, Napieralska, Aleksandra, Namysl-Kaletka, Agnieszka, Prionas, Nicholas D., Bagshaw, Hilary, Buyyounouski, Mark K., Cao, Minsong, Mahal, Brandon A., Shabsovich, David, Dang, Audrey, Yuan, Ye, Rettig, Matthew B., Chang, Albert J., Jackson, William C., Spratt, Daniel E., Lehrer, Eric J., Zaorsky, Nicholas G., Kupelian, Patrick A., Steinberg, Michael L., Horwitz, Eric M., Jiang, Naomi Y., Kishan, Amar U.

“…•The kinetics of PSA decline differed between SBRT, HDR-BT, and LDR-BT.•Lower nPSA, longer decay to nPSA, and greater achievement of PSA <0.2 ng/mL was seen…”
Get full text

A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature by Tirado, Carlos A, Siangchin, Ken, Shabsovich, David S, Sharifian, Maryam, Schiller, Gary

“…Acute myeloid leukemia (AML) is commonly characterized by several chromosomal abnormalities resulting in the formation of chimeric genes that play various…”
Get full text

Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer by Dang, Audrey T., Levin-Epstein, Rebecca G., Shabsovich, David, Cao, Minsong, King, Christopher, Chu, Fang-I., Mantz, Constantine A., Stephans, Kevin L., Reddy, Chandana A., Loblaw, D. Andrew, Cheung, Patrick, Scorsetti, Marta, Cozzi, Luca, DeNittis, Albert S., Wang, Yue, Zaorsky, Nicholas, Nickols, Nicholas G., Kupelian, Patrick A., Steinberg, Michael L., Kishan, Amar U.

“…To establish the safety and efficacy of gantry-mounted linear accelerator-based stereotactic body radiation therapy (SBRT) for low- and intermediate-risk…”
Get full text

B-Lymphoblastic Leukemia Presenting with Eosinophilia: A Case Report and Review by Shabsovich, David, Maranzano, Michael J., Said, Jonathan, Ku, Nam, Pullarkat, Sheeja, Schiller, Gary J.

“…B-lymphoblastic leukemia (B-ALL) presenting with eosinophilia represents a rare entity. In particular, the unique clinical manifestations as well as the…”
Get full text

PRIMARY CARDIAC LYMPHOMA WITH LOCOREGIONAL LYMPH NODE INVOLVEMENT PRESENTING WITH COMPLETE HEART BLOCK by Bachour, Kinan, Shah, Sagar, Chia, Jennifer, Shabsovich, David, Reichl, Allison, Castillo, Adrian, Cho, Geoffrey Weiting

Get full text

Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy by Yoon, Stephanie, Cao, Minsong, Aghdam, Nima, Shabsovich, David, Kahlon, Sartajdeep, Ballas, Leslie, Collins, Sean, Steinberg, Michael Lee, Kishan, Amar U.

“…•Stabilizing organ-at-risk anatomy (OAR) is essential.•Interfraction prostate bed volume is stable despite deformable surrounding organs.•Target underdosing…”
Get full text

PD08-09 META-ANALYSIS OF RADIATION THERAPY AND ANDROGEN DEPRIVATION THERAPY IN LOCALIZED PROSTATE CANCER by Jiang, Tommy, Markovic, Daniela, Patel, Jay, Juarez, Jesus, Ma, Martin, Shabsovich, David, Zaorsky, Nicholas, Nickols, Nicholas, Reiter, Robert, Elashoff, David, Rettig, Matthew, Spratt, Daniel, Kishan, Amar

Get full text

97: Four-Year PSA Response Rate as a Predictive Measure in Intermediate Risk Prostate Cancer Treated with Ablative Therapies: The Sprat Analysis by Glicksman, Rachel, Kishan, Amar U., Katz, Alan J., Mantz, Constantine A., Collins, Sean P., Fuller, Donald B., Steinberg, Michael L., Shabsovich, David, Zhang, Liying, Loblaw, Andrew

Get full text

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control by Levin-Epstein, Rebecca G., Jiang, Naomi Y., Wang, Xiaoyan, Upadhyaya, Shrinivasa K., Collins, Sean P., Suy, Simeng, Aghdam, Nima, Mantz, Constantine, Katz, Alan J., Miszczyk, Leszek, Napieralska, Aleksandra, Namysl-Kaletka, Agnieszka, Prionas, Nicholas, Bagshaw, Hilary, Buyyounouski, Mark K., Cao, Minsong, Agazaryan, Nzhde, Dang, Audrey, Yuan, Ye, Kupelian, Patrick A., Zaorsky, Nicholas G., Spratt, Daniel E., Mohamad, Osama, Feng, Felix Y., Mahal, Brandon A., Boutros, Paul C., Kishan, Arun U., Juarez, Jesus, Shabsovich, David, Jiang, Tommy, Kahlon, Sartajdeep, Patel, Ankur, Patel, Jay, Nickols, Nicholas G., Steinberg, Michael L., Fuller, Donald B., Kishan, Amar U.

“…•Dose-escalation was associated with greater prostate ablation and PSA decay.•All dose groups in our study achieved median nPSAs of ≤0.2 ng/mL.•Dose-escalation…”
Get full text

Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy by Jiang, Naomi Y., Dang, Audrey T., Yuan, Ye, Chu, Fang-I, Shabsovich, David, King, Christopher R., Collins, Sean P., Aghdam, Nima, Suy, Simeng, Mantz, Constantine A., Miszczyk, Leszek, Napieralska, Aleksandra, Namysl-Kaletka, Agnieszka, Bagshaw, Hilary, Prionas, Nicolas, Buyyounouski, Mark K., Jackson, William C., Spratt, Daniel E., Nickols, Nicholas G., Steinberg, Michael L., Kupelian, Patrick A., Kishan, Amar U.

“…Understanding prostate-specific antigen (PSA) kinetics after radiation therapy plays a large role in the management of patients with prostate cancer (PCa)…”
Get full text

Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials by Jiang, Tommy, Markovic, Daniela, Patel, Jay, Juarez, Jesus E., Ma, Ting Martin, Shabsovich, David, Nickols, Nicholas G., Reiter, Robert E., Elashoff, David, Rettig, Matthew B., Zaorsky, Nicholas G., Spratt, Daniel E., Kishan, Amar U.

“…Background While multiple randomized trials have evaluated the benefit of radiation therapy (RT) dose escalation and the use and prolongation of androgen…”
Get full text

41 - Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia With a Complex Karyotype by Shabsovich, David, Naeini, Yalda, Tirado, Carlos A.

Get full text

Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer by Philipson, Rebecca G., Romero, Tahmineh, Wong, Jessica K., Stish, Bradley J., Dess, Robert T., Spratt, Daniel E., Pilar, Avinash, Reddy, Chandana, Wedde, Trude B., Lilleby, Wolfgang A., Fiano, Ryan, Merrick, Gregory S., Stock, Richard G., Demanes, D. Jeffrey, Moran, Brian J., Braccioforte, Michelle, Tran, Phuoc T., Martin, Santiago, Martinez-Monge, Rafael, Krauss, Daniel J., Abu-Isa, Eyad I., Valle, Luca, Chong, Natalie, Pisansky, Thomas M., Choo, C. Richard, Song, Daniel Y., Greco, Stephen, Deville, Curtiland, McNutt, Todd, DeWeese, Theodore L., Ross, Ashley E., Ciezki, Jay P., Tilki, Derya, Karnes, R. Jeffrey, Klein, Eric A., Tosoian, Jeffrey J., Boutros, Paul C., Nickols, Nicholas G., Bhat, Prashant, Shabsovich, David, Juarez, Jesus E., Kupelian, Patrick A., Rettig, Matthew B., Berlin, Alejandro, Tward, Jonathan D., Davis, Brian J., Reiter, Robert E., Steinberg, Michael L., Elashoff, David, Horwitz, Eric M., Tendulkar, Rahul D., Kishan, Amar U.

“…The natural history of radiorecurrent high-risk prostate cancer (HRPCa) is not well-described. To better understand its clinical course, we evaluated rates of…”
Get full text

Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review by Valle, Luca, Shabsovich, David, de Meerleer, Gert, Maurer, Tobias, Murphy, Declan G., Nickols, Nicholas G., Vapiwala, Neha, Calais, Jeremie, Kishan, Amar U.

“…The use, common findings, and impact of modern molecular positron emission tomography (PET)/computed tomography (CT) imaging prior to salvage radiation therapy…”
Get full text

Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia With a Complex Karyotype by Shabsovich, David, Naeini, Yalda, Tirado, Carlos A

Get full text

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts by Kishan, Amar U, Steigler, Alison, Denham, James W, Zapatero, Almudena, Guerrero, Araceli, Joseph, David, Maldonado, Xavier, Wong, Jessica K, Stish, Bradley J, Dess, Robert T, Pilar, Avinash, Reddy, Chandana, Wedde, Trude B, Lilleby, Wolfgang A, Fiano, Ryan, Merrick, Gregory S, Stock, Richard G, Demanes, D Jeffrey, Moran, Brian J, Tran, Phuoc T, Martin, Santiago, Martinez-Monge, Rafael, Krauss, Daniel J, Abu-Isa, Eyad I, Pisansky, Thomas M, Choo, C Richard, Song, Daniel Y, Greco, Stephen, Deville, Curtiland, McNutt, Todd, DeWeese, Theodore L, Ross, Ashley E, Ciezki, Jay P, Tilki, Derya, Karnes, R Jeffrey, Tosoian, Jeffrey J, Nickols, Nicholas G, Bhat, Prashant, Shabsovich, David, Juarez, Jesus E, Jiang, Tommy, Ma, T Martin, Xiang, Michael, Philipson, Rebecca, Chang, Albert, Kupelian, Patrick A, Rettig, Matthew B, Feng, Felix Y, Berlin, Alejandro, Tward, Jonathan D, Davis, Brian J, Reiter, Robert E, Steinberg, Michael L, Elashoff, David, Boutros, Paul C, Horwitz, Eric M, Tendulkar, Rahul D, Spratt, Daniel E, Romero, Tahmineh

“…Radiotherapy combined with androgen deprivation therapy (ADT) is a standard of care for high-risk prostate cancer. However, the interplay between radiotherapy…”
Get more information

Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging by Ma, Ting Martin, Gafita, Andrei, Shabsovich, David, Juarez, Jesus, Grogan, Tristan R., Thin, Pan, Armstrong, Wesley, Sonni, Ida, Nguyen, Kathleen, Lok, Vincent, Reiter, Robert E., Rettig, Matthew B., Steinberg, Michael L., Kupelian, Patrick A., Yang, David D., Muralidhar, Vinayak, Chu, Carissa, Feng, Felix, Savjani, Ricky, Deng, Jie, Parikh, Neil R., Nickols, Nicholas G., Elashoff, David, Czernin, Johannes, Calais, Jeremie, Kishan, Amar U.

“…Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is an emerging imaging modality with greater sensitivity…”
Get full text

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer by Xiang, Michael, Ma, Ting Martin, Savjani, Ricky, Pollom, Erqi L, Karnes, R Jeffrey, Grogan, Tristan, Wong, Jessica K, Motterle, Giovanni, Tosoian, Jeffrey J, Trock, Bruce J, Klein, Eric A, Stish, Bradley J, Dess, Robert T, Spratt, Daniel E, Pilar, Avinash, Reddy, Chandana, Levin-Epstein, Rebecca, Wedde, Trude B, Lilleby, Wolfgang A, Fiano, Ryan, Merrick, Gregory S, Stock, Richard G, Demanes, D Jeffrey, Moran, Brian J, Huland, Hartwig, Tran, Phuoc T, Martin, Santiago, Martinez-Monge, Rafael, Krauss, Daniel J, Abu-Isa, Eyad I, Alam, Ridwan, Schwen, Zeyad, Pisansky, Thomas M, Choo, C Richard, Song, Daniel Y, Greco, Stephen, Deville, Curtiland, McNutt, Todd, DeWeese, Theodore L, Ross, Ashley E, Ciezki, Jay P, Boutros, Paul C, Nickols, Nicholas G, Bhat, Prashant, Shabsovich, David, Juarez, Jesus E, Chong, Natalie, Kupelian, Patrick A, Rettig, Matthew B, Zaorsky, Nicholas G, Berlin, Alejandro, Tward, Jonathan D, Davis, Brian J, Reiter, Robert E, Steinberg, Michael L, Elashoff, David, Horwitz, Eric M, Tendulkar, Rahul D, Tilki, Derya, Czernin, Johannes, Gafita, Andrei, Romero, Tahmineh, Calais, Jeremie, Kishan, Amar U

“…Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) can detect low-volume, nonlocalized (ie, regional or…”
Get full text

Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features by Kishan, Amar U, Karnes, R Jeffrey, Romero, Tahmineh, Wong, Jessica K, Motterle, Giovanni, Tosoian, Jeffrey J, Trock, Bruce J, Klein, Eric A, Stish, Bradley J, Dess, Robert T, Spratt, Daniel E, Pilar, Avinash, Reddy, Chandana, Levin-Epstein, Rebecca, Wedde, Trude B, Lilleby, Wolfgang A, Fiano, Ryan, Merrick, Gregory S, Stock, Richard G, Demanes, D Jeffrey, Moran, Brian J, Braccioforte, Michelle, Huland, Hartwig, Tran, Phuoc T, Martin, Santiago, Martínez-Monge, Rafael, Krauss, Daniel J, Abu-Isa, Eyad I, Alam, Ridwan, Schwen, Zeyad, Chang, Albert J, Pisansky, Thomas M, Choo, Richard, Song, Daniel Y, Greco, Stephen, Deville, Curtiland, McNutt, Todd, DeWeese, Theodore L, Ross, Ashley E, Ciezki, Jay P, Boutros, Paul C, Nickols, Nicholas G, Bhat, Prashant, Shabsovich, David, Juarez, Jesus E, Chong, Natalie, Kupelian, Patrick A, D'Amico, Anthony V, Rettig, Matthew B, Berlin, Alejandro, Tward, Jonathan D, Davis, Brian J, Reiter, Robert E, Steinberg, Michael L, Elashoff, David, Horwitz, Eric M, Tendulkar, Rahul D, Tilki, Derya

“…The optimal management strategy for high-risk prostate cancer and additional adverse clinicopathologic features remains unknown. To compare clinical outcomes…”
Get full text